Venomics AI Raises $2.7 Million to Develop Venom-Derived Therapeutic Molecules
Venomics AI, a biotechnology startup spun out of the Indian Institute of Science, has raised $2.7 million in a pre-seed funding round led by Speciale Invest and South Park Commons. The company uses venom biology, artificial intelligence, and experimental screening to discover and develop venom-derived molecules into potential therapeutic drugs. The funding will support expansion of its Venom Atlas molecular dataset, enhance AI and laboratory capabilities, and grow its multidisciplinary team focused on drug discovery from animal venoms.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 47/100.
Outlets measured: inc42media, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Nov, 10:28 am. Other outlets followed.
- 1